Zibo Xinhua Perrigo Pharmaceutical

Zibo Xinhua Perrigo Pharmaceutical is a joint venture between Shandong Xinhua Pharmaceutical and Perrigo Company plc, specializing in the manufacture of over-the-counter (OTC) pharmaceutical products and active pharmaceutical ingredients (APIs). The company operates state-of-the-art, FDA-approved facilities in Zibo, China, primarily focused on the large-scale production of analgesics such as ibuprofen. By combining Xinhua's extensive manufacturing infrastructure with Perrigo's global market leadership in consumer self-care, the venture serves as a critical supplier for international healthcare markets. Their operations emphasize high-quality, cost-efficient production of essential medicines in various finished dosage forms. The partnership represents a strategic alignment to provide affordable healthcare solutions globally.